Subcutaneous mosunetuzumab in relapsed or refractory B-cell lymphoma: Promising safety and encouraging efficacy in dose escalation cohorts Meeting Abstract
| Authors: | Matasar, M. J.; Cheah, C. Y.; Yoon, D. H.; Assouline, S. E.; Bartlett, N. L.; Ku, M.; Giri, P.; Johnston, A.; Flinn, I. W.; Goy, A. H.; Tzachanis, D.; O'Hear, C.; Yin, S.; To, I.; Sarouei, K.; Li, C. C.; Bender, B. C.; Penuel, E. M.; Huang, H.; Budde, L. E. |
| Abstract Title: | Subcutaneous mosunetuzumab in relapsed or refractory B-cell lymphoma: Promising safety and encouraging efficacy in dose escalation cohorts |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607205606068 |
| DOI: | 10.1182/blood-2020-135818 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 45 -- Source: Wos |
